Home › Funds › Vanguard Group › NMRA
Vanguard Group position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q4 2025)4.54M sh
Reported value held$8.13M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 50.00K | $705.50K | New |
| Q4 2023 | 380.95K | $6.50M | Add |
| Q1 2024 | 334.33K | $4.60M | Reduce |
| Q2 2024 | 3.27M | $32.18M | Add |
| Q3 2024 | 4.38M | $57.82M | Add |
| Q4 2024 | 4.57M | $48.47M | Add |
| Q1 2025 | 5.33M | $5.33M | Add |
| Q2 2025 | 4.76M | $3.49M | Reduce |
| Q3 2025 | 4.05M | $7.37M | Reduce |
| Q4 2025 | 4.54M | $8.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026
- Goldman Sachs Group 303.86K sh · $516.57K · Q2 2026